The Global Duchenne Muscular Dystrophy Market size was accounted for $1,304.44 Million in 2023, and is estimated to reach $2,075.9 Million by 2031, growing at a CAGR of 5.2% from 2024 to 2031.  The Duchenne Muscular Dystrophy (DMD) therapeutics market is driven by advancements in genetic research, fostering innovative treatments like gene therapies and exon-skipping technologies....